{"id":"NCT02634307","sponsor":"Biogen","briefTitle":"A Study of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis (MS) EVOLVE-MS-1","officialTitle":"A Phase 3 Open Label Study to Evaluate the Long-term Safety and Tolerability of ALKS 8700 in Adults With Relapsing Remitting Multiple Sclerosis","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-12-10","primaryCompletion":"2021-06-01","completion":"2021-11-11","firstPosted":"2015-12-18","resultsPosted":"2022-06-24","lastUpdate":"2022-07-26"},"enrollment":1057,"design":{"allocation":"NA","model":"SINGLE_GROUP","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Multiple Sclerosis"],"interventions":[{"type":"DRUG","name":"ALKS 8700","otherNames":[]}],"arms":[{"label":"ALKS 8700","type":"EXPERIMENTAL"}],"summary":"The primary objective of this study is to evaluate the long-term safety and tolerability of ALKS 8700 for the treatment of Relapsing Remitting Multiple Sclerosis (RRMS). The secondary objective of this study is to evaluate treatment effect over time in adult participants with RRMS treated with ALKS 8700.","primaryOutcome":{"measure":"Number of Participants Experiencing Treatment Emergent Adverse Events (TEAEs) and Serious Adverse Events (SAEs)","timeFrame":"From first dose to two weeks after last dose of study drug (Up to 98 weeks)","effectByArm":[{"arm":"De Novo","deltaMin":519,"sd":null},{"arm":"Rollover: ALKS 8700","deltaMin":212,"sd":null},{"arm":"Rollover: DMF","deltaMin":207,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":2,"exclusionCount":4},"locations":{"siteCount":115,"countries":["United States","Belgium","Bulgaria","Canada","Germany","Poland","Russia","Serbia","Spain","Ukraine"]},"refs":{"pmids":["38935202","38878121","37155132","35211872","31680631","31538304"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":69,"n":593},"commonTop":["Flushing","Multiple sclerosis relapse","Upper respiratory tract infection","Nasopharyngitis","Lymphopenia"]}}